1. Home
  2. POAI vs LCFY Comparison

POAI vs LCFY Comparison

Compare POAI & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • LCFY
  • Stock Information
  • Founded
  • POAI 2002
  • LCFY 2009
  • Country
  • POAI United States
  • LCFY Australia
  • Employees
  • POAI N/A
  • LCFY N/A
  • Industry
  • POAI Industrial Specialties
  • LCFY
  • Sector
  • POAI Health Care
  • LCFY
  • Exchange
  • POAI Nasdaq
  • LCFY Nasdaq
  • Market Cap
  • POAI 9.7M
  • LCFY 7.3M
  • IPO Year
  • POAI N/A
  • LCFY 2022
  • Fundamental
  • Price
  • POAI $1.46
  • LCFY $6.44
  • Analyst Decision
  • POAI Hold
  • LCFY
  • Analyst Count
  • POAI 1
  • LCFY 0
  • Target Price
  • POAI N/A
  • LCFY N/A
  • AVG Volume (30 Days)
  • POAI 2.8M
  • LCFY 21.6K
  • Earning Date
  • POAI 03-27-2025
  • LCFY 04-01-2025
  • Dividend Yield
  • POAI N/A
  • LCFY N/A
  • EPS Growth
  • POAI N/A
  • LCFY N/A
  • EPS
  • POAI N/A
  • LCFY N/A
  • Revenue
  • POAI $1,484,223.00
  • LCFY $2,668,385.00
  • Revenue This Year
  • POAI N/A
  • LCFY N/A
  • Revenue Next Year
  • POAI $569.48
  • LCFY N/A
  • P/E Ratio
  • POAI N/A
  • LCFY N/A
  • Revenue Growth
  • POAI N/A
  • LCFY N/A
  • 52 Week Low
  • POAI $0.55
  • LCFY $2.20
  • 52 Week High
  • POAI $3.76
  • LCFY $11.23
  • Technical
  • Relative Strength Index (RSI)
  • POAI 55.86
  • LCFY 38.08
  • Support Level
  • POAI $1.39
  • LCFY $5.80
  • Resistance Level
  • POAI $1.58
  • LCFY $8.00
  • Average True Range (ATR)
  • POAI 0.12
  • LCFY 0.66
  • MACD
  • POAI -0.02
  • LCFY -0.23
  • Stochastic Oscillator
  • POAI 41.94
  • LCFY 17.83

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has three operating segments: the Publishing segment, the Reseller segment, and the Channel sales segment. It derives a majority of its revenue from Australia and New Zealand.

Share on Social Networks: